Cargando…

Prognostic impact of a history of cancer and atrial fibrillation in antithrombotic therapy for chronic heart failure

AIMS: This study aimed to examine the prognostic significance of a history of cancer and atrial fibrillation (AF) in antithrombotic therapy for patients with chronic heart failure (CHF). METHODS AND RESULTS: We enrolled consecutive 4876 CHF patients (69 ± 12 years; women, 31.9%) in our multicentre,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nochioka, Kotaro, Yasuda, Satoshi, Sakata, Yasuhiko, Shiroto, Takashi, Hayashi, Hideka, Takahashi, Jun, Takahama, Hiroyuki, Miyata, Satoshi, Shimokawa, Hiroaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288778/ https://www.ncbi.nlm.nih.gov/pubmed/35434966 http://dx.doi.org/10.1002/ehf2.13941

Ejemplares similares

Long-term prognostic significance of history of cancer and atrial fibrillation in coronary artery disease
por: Nochioka, Kotaro, et al.
Publicado: (2023)

Utilization and Efficacy of Cardiac Resynchronization Therapy in Patients With Chronic Heart Failure　― A Report From the CHART-2 Study ―
por: Hayashi, Hideka, et al.
Publicado: (2022)

Risk prediction for new-onset atrial fibrillation using the Minnesota code electrocardiography classification system
por: Igarashi, Yu, et al.
Publicado: (2021)

Prognostic impacts of dynamic cardiac structural changes in heart failure patients with preserved left ventricular ejection fraction
por: Yamanaka, Shinsuke, et al.
Publicado: (2020)

Prognostic impacts of serum uric acid levels in patients with chronic heart failure: insights from the CHART‐2 study
por: Fujihashi, Takahide, et al.
Publicado: (2020)

Clinical characteristics and prognostic factors in elderly patients with chronic heart failure -A report from the CHART-2 study-
por: Sato, Masayuki, et al.
Publicado: (2020)

Serial assessment of cardiothoracic ratio as a predictor of progression from stage B to stage C heart failure in asymptomatic patients with cardiac diseases
por: Nochioka, Kotaro, et al.
Publicado: (2023)

Prognostic Impact of Statin Intensity in Heart Failure Patients With Ischemic Heart Disease: A Report From the CHART‐2 (Chronic Heart Failure Registry and Analysis in the Tohoku District 2) Study
por: Oikawa, Takuya, et al.
Publicado: (2018)

Machine learning approach to stratify complex heterogeneity of chronic heart failure: A report from the CHART‐2 study
por: Nakano, Kenji, et al.
Publicado: (2023)

Coronary Microvascular Spasm: Clinical Presentation and Diagnosis
por: Godo, Shigeo, et al.
Publicado: (2023)

Inhaled nitric oxide testing in predicting prognosis in pulmonary hypertension due to left‐sided heart diseases
por: Satoh, Taijyu, et al.
Publicado: (2023)

Prognostic Impacts of Comorbid Significant Coronary Stenosis and Coronary Artery Spasm in Patients With Stable Coronary Artery Disease
por: Hao, Kiyotaka, et al.
Publicado: (2021)

Impaired glucose tolerance and albuminuria in patients with chronic heart failure: a subanalysis of the SUPPORT trial
por: Nochioka, Kotaro, et al.
Publicado: (2019)

Persistent or permanent atrial fibrillation is associated with severe cardioembolic stroke in patients with non-valvular atrial fibrillation
por: Hagii, Joji, et al.
Publicado: (2021)

The use of antithrombotics in patients presenting with stroke and atrial fibrillation
por: Burgess, Carl, et al.
Publicado: (2007)

Update on Antithrombotic Therapy for Stroke Prevention in Atrial Fibrillation
por: Abcede, Hermelinda G., et al.
Publicado: (2010)

The sunset of triple antithrombotic therapy for atrial fibrillation patients
por: Capranzano, Piera
Publicado: (2019)

Comorbidities and Antithrombotic Treatment Pattern in Patients With Atrial Fibrillation
por: Bang, Oh Young, et al.
Publicado: (2022)

Atrial fibrillation: trends in prevalence and antithrombotic prescriptions in the community
por: Joosten, L. P. T., et al.
Publicado: (2022)

Antithrombotic therapy in atrial fibrillation: aspirin is rarely the right choice
por: Sabir, Ian N, et al.
Publicado: (2013)

Antithrombotic therapy in coronary artery disease patients with atrial fibrillation
por: Wei, Lili, et al.
Publicado: (2020)

Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome
por: Bor, Wilbert, et al.
Publicado: (2020)

Antithrombotic therapy in patients with atrial fibrillation and coronary artery disease
por: Moustafa, Abdelmoniem, et al.
Publicado: (2019)

Post‐Intracranial Hemorrhage Antithrombotic Therapy in Patients With Atrial Fibrillation
por: Lin, Shin‐Yi, et al.
Publicado: (2022)

Antithrombotic Therapy for Atrial Fibrillation and Coronary Artery Disease in Patients With Prior Atherothrombotic Disease: A Post Hoc Analysis of the AFIRE Trial
por: Matsuzawa, Yasushi, et al.
Publicado: (2021)

Antithrombotic treatment in elderly patients with atrial fibrillation: a practical approach
por: Suárez Fernández, Carmen, et al.
Publicado: (2015)

Impact of Antithrombotic Therapy in Atrial Fibrillation on the Presentation of Coronary Artery Disease
por: Chan, Pak Hei, et al.
Publicado: (2015)

Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation
por: Camm, A John, et al.
Publicado: (2017)

Antithrombotic Strategy in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention
por: Kwak, Soongu, et al.
Publicado: (2019)

Atrial fibrillation and comorbidities: Clinical characteristics and antithrombotic treatment in GLORIA-AF
por: Kozieł, Monika, et al.
Publicado: (2021)

Antithrombotic treatment in atrial fibrillation patients needing percutaneous coronary intervention
por: Huisman, M. V.
Publicado: (2021)

Antioxidant Properties of Oral Antithrombotic Therapies in Atherosclerotic Disease and Atrial Fibrillation
por: Falco, Luigi, et al.
Publicado: (2023)

Temporal Trends in Antithrombotic Therapy for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention From 2014 to 2022 in Japan
por: Nakano, Yasuhiro, et al.
Publicado: (2023)

Sex differences in hemodynamic responses and long-term survival to optimal medical therapy in patients with pulmonary arterial hypertension
por: Kozu, Katsuya, et al.
Publicado: (2018)

Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation After Coronary Stent Implantation
por: Jang, Sung-Won, et al.
Publicado: (2011)

Antithrombotic alternatives for stroke prevention in atrial fibrillation: critical differences and remaining questions
por: Kalus, James S
Publicado: (2013)

Erratum: Antithrombotic treatment in elderly patients with atrial fibrillation: a practical approach
por: Fernández, Carmen Suárez, et al.
Publicado: (2015)

Optimal long-term antithrombotic management of atrial fibrillation: life cycle management
por: Pisters, R., et al.
Publicado: (2018)

Atrial fibrillation, antithrombotic treatment, and cognitive aging: A population-based study
por: Ding, Mozhu, et al.
Publicado: (2018)

Antithrombotic management of patients with atrial fibrillation—Dutch anticoagulant initiatives anno 2020
por: Chu, G., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ammjbn2ilfocrsjisv05bco19s